Moleculin Biotech, Inc. — Director's Dealing 2019

May 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2019-05-22

Reporting Person: George Robert E. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-22	Stock option (right to buy)	$1.15	A	15000	Acquired	2029-05-22	Common Stock (15000)	Direct

Footnotes

F1: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

F2: The options were issued in connection with the reporting person's Board of Director service to the Company.